Swiss pharmaceutical giant Roche has experienced an improved revenue this year. However, it also saw a decline in market cap as its invetors remain cautious on broader industry factors.
market cap
Breaking News
Subscribe to VCpost newsletter
Most Popular
- SSDI Payment April 2024: Who Will Receive Social Security Benefits Today?
- Tesla Spends $200,000 in Promoting Elon Musk's Social Media Platform X Following Mention of 'Minimal Advertising Efforts'
- Trump Media’s First Auditor Quits After Just a Few Months on the Job: Report
- UPDATE: Google Employees Arrested and Fired After Staging Protests Over Company's Project Nimbus Deal With Israel
- US Plans to Lift Tariff Exceptions to Dominant Chinese Solar Panel Imports as Biden Accuses Beijing of 'Cheating' on Its Steel Trade Pactices
- Social Security Benefits: 2025 COLA Predicted to Increase Amid Rising Inflation
- Telegram Russian Founder Says Messaging App to Cross 1 Billion User Mark Soon as It Continues to Remain a 'Neutral Platform'
- Governors in 6 Southern States Warn Workers Against Joining UAW Union, Say Unionization Places Jobs in Jeopardy
